NEW YORK SOCIETY FOR GASTROINTESTINAL ENDOSCOPY (EIN 132846619) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1976

Legal Domicile

Principal Officer

REEM SHARAIHA

Phone

8477525355

Tax Period

2024-07-01 to 2025-06-30

NEW YORK SOCIETY FOR GASTROINTESTINAL ENDOSCOPY, founded in 1976, is a community nonprofit that reported $1.4M in total revenue in fiscal year 2024. Revenue surged 28% from the prior year, signaling strong growth momentum. Expenses of $1.3M left a modest 6% surplus.

Mission

ADVANCE EXCELLENCE IN GASTROENTEROLOGY AND GASTROINTESTINAL ENDOSCOPY; TO DISSEMINATE RELATED KNOWLEDGE, AND TO TEACH ENDOSCOPIC SKILLS IN AN INCLUSIVE ENVIRONMENT THAT ENHANCES PROFESSIONAL DEVELOPMENT AND OPTIMIZES PATIENT CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $164,884

Program Service Revenue $1,217,915

Investment Income $26,534

Other Revenue $0

TOTAL REVENUE $1,409,333

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $987,625

Other Expenses $1,317,964

TOTAL EXPENSES $1,317,964

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,409,333	$1,100,961	+0.3%
Expenses	$1,317,964	$1,377,201	0.0%
Net Income	$91,369	$-276,240	-1.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SHERIF ANDRAWES	SECRETARY	N/A	Director	$0	$0	$0
OLGA ARONIADIS	COUNCILOR	N/A	Director	$0	$0	$0
PETROS BENIAS	COUNCILOR	N/A	Director	$0	$0	$0
BRIAN BOSWORTH	AUDIT COMMIT	N/A	Director	$0	$0	$0
CARL CRAWFORD	COUNCILOR	N/A	Director	$0	$0	$0
TAMAS GONDA	VICE PRESIDE	N/A	Officer Director	$0	$0	$0
DAVID GREENWALD	COUNCILOR	N/A	Director	$0	$0	$0
SETH GROSS	COUNCILOR	N/A	Director	$0	$0	$0
LAUREN KHANNA	COUNCILOR	N/A	Director	$0	$0	$0
SONAL KUMAR	COUNCILOR	N/A	Director	$0	$0	$0
NIKHIL KUMTA	MEMBERSHIP D	N/A	Director	$0	$0	$0
JUAN CARLOS BUCOBO MD	PAST PRESIDE	N/A	Officer Director	$0	$0	$0
SRIHARI MAHADEV	COUNCILOR	N/A	Director	$0	$0	$0
ROBIN MENDELSOHN	TREASURER	N/A	Officer Director	$0	$0	$0
SUE O'SULLIVAN	EXEC. DIRECT	N/A	Director	$0	$0	$0
DR HALEH PAZWASH	COUNCILOR	N/A	Director	$0	$0	$0
JOHN PONEROS	IMM PAST PRE	N/A	Officer Director	$0	$0	$0
KARTIK SAMPATH	COUNCILOR	N/A	Director	$0	$0	$0
REEM SHARAIHA	PRESIDENT	N/A	Officer Director	$0	$0	$0
ANTHONY STARPOLI	WEBSITE, TEC	N/A	Director	$0	$0	$0
KAVEL VISRODIA	COUNCILOR	N/A	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,409,333	$1,317,964	$1,253,612	$91,369
2024	$1,100,961	$1,364,751	$1,072,778	$-263,790
2023	$1,001,392	$1,181,155	$1,248,214	$-179,763
2022	$937,994	$1,006,898	$1,314,526	$-68,904
2021	$400,548	$385,023	$1,405,776	$15,525
2020	$1,137,416	$1,175,166	$1,303,596	$-37,750
2019	$1,288,701	$1,276,880	$1,700,721	$11,821
2018	$1,281,581	$1,149,560	$1,640,118	$132,021

NEW YORK SOCIETY FOR GASTROINTESTINAL ENDOSCOPY